XRCC1 and cancer: Here we show that, in the absence of XRCC1, PARP1 can become excessively engaged on BER intermediates in a manner similar to that induced by anti-cancer PARP1 inhibitors, demonstrating that PARP1 trapping is a threat to normal genome integrity.